5 Things Illumina's Management Just Said That You'll Really Want to Know
High-flying Illumina (NASDAQ: ILMN) definitely hit a speed bump with its second-quarter results. Investors accustomed to double-digit sales and earnings growth weren't happy with the gene-sequencing pioneer's anemic 1% year-over-year revenue increase and its nearly 6% drop in adjusted earnings.
As you might expect, Illumina's executives had plenty to say about this lackluster performance in the company's Q2 conference call on Monday. Here are five things they stated that you'll really want to know.
Image source: Getty Images.
Quelle Fool.com
